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Abstract
Introduction: Protective ventilation by using limited airway pressures and ventilation may result in moderate and
prolonged hypercapnic acidosis, as often observed in critically ill patients. Because allowing moderate and
prolonged hypercapnia may be considered protective measure for the lungs, we hypothesized that moderate and
prolonged hypercapnic acidosis may protect the diaphragm against ventilator-induced diaphragmatic dysfunction
(VIDD). The aim of our study was to evaluate the effects of moderate and prolonged (72 hours of mechanical
ventilation) hypercapnic acidosis on in vivo diaphragmatic function.
Methods: Two groups of anesthetized piglets were ventilated during a 72-hour period. Piglets were assigned to the
Normocapnia group (n = 6), ventilated in normocapnia, or to the Hypercapnia group (n = 6), ventilated with moderate
hypercapnic acidosis (PaCO2 from 55 to 70 mm Hg) during the 72-hour period of the study. Every 12 hours, we
measured transdiaphragmatic pressure (Pdi) after bilateral, supramaximal transjugular stimulation of the two phrenic
nerves to assess in vivo diaphragmatic contractile force. Pressure/frequency curves were drawn after stimulation from 20
to 120 Hz of the phrenic nerves. The protocol was approved by our institutional animal-care committee.
Results: Moderate and prolonged hypercapnic acidosis was well tolerated during the study period. The baseline
pressure/frequency curves of the two groups were not significantly different (Pdi at 20 Hz, 32.7 ± 8.7 cm H2O,
versus 34.4 ± 8.4 cm H2O; and at 120 Hz, 56.8 ± 8.7 cm H2O versus 60.8 ± 5.7 cm H2O, for Normocapnia and
Hypercapnia groups, respectively). After 72 hours of ventilation, Pdi decreased by 25% of its baseline value in the
Normocapnia group, whereas Pdi did not decrease in the Hypercapnia group.
Conclusions: Moderate and prolonged hypercapnic acidosis limited the occurrence of VIDD during controlled
mechanical ventilation in a healthy piglet model. Consequences of moderate and prolonged hypercapnic acidosis
should be better explored with further studies before being tested on patients.
Introduction
Mechanical ventilation is a lifesaving technique and a lead-
ing treatment of acute respiratory failure in the intensive
care unit (ICU). In the earliest stages of acute respiratory
failure, maintaining respiratory muscles at rest, in
particular the diaphragm, is frequently performed, the bet-
ter to synchronize the patient and the ventilator. The ven-
tilator settings often use a totally controlled mode and are
combined with deep sedation to avoid spontaneous venti-
lator cycles. One of the consequences of resting respira-
tory muscles is the occurrence of ventilator-induced
diaphragmatic dysfunction (VIDD) [1-3], largely described
in animal models and more sparsely, but recently, in
human studies [4-8]. Another complication of mechanical
ventilation is the occurrence of ventilator-induced lung
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injury (VILI), which is magnified when high alveolar pres-
sures and volumes are applied [9], even in healthy lungs
[10,11]. As a consequence, the historic goal of mechanical
ventilation, normalizing the gas exchange, has evolved
toward preventing lung injury by reducing alveolar pres-
sure and lung volume, at the cost of reduced gas exchange.
This concept, labeled protective ventilation, may lead to a
permissive hypercapnic acidosis, which is well tolerated
when not so severe (pH > 7.20 with PaCO2 < 60 to 65 mm
Hg) [12]. Furthermore, some studies have shown a poten-
tial beneficial effect of moderate and prolonged hypercap-
nic acidosis per se on lung inflammation in animal models
of experimental pneumonia [13], and it may prevent
hypoxia-induced oxydative stress in the lungs [14] and
NF-B activation in pulmonary endothelial cells exposed
to lipopolysaccharide [15]. Hypercapnic acidosis may also
inhibit endogenous xanthine oxidase activity and then
may decrease reactive oxygen species [16]. Conversely,
acute and severe hypercapnic acidosis has been shown to
impair diaphragmatic contractile properties both in vitro
[17-19] and in vivo [17,20].
Because reactive oxygen species production and the NF-
B pathway play major roles in VIDD [2] and because
these pathways can be modulated with hypercapnic acido-
sis, we conducted an animal study and compared the
effects of moderate and prolonged hypercapnic acidosis
(72 continuous hours) versus normocapnia in a totally
controlled mechanically ventilated healthy piglet model on
in vivo VIDD. Our hypothesis was that moderate and pro-
longed hypercapnic acidosis may protect the diaphragm
against VIDD.
Materials and methods
The study followed the guidelines for animal experiments
established by the institutional animal care committee
(INSERM U 1046, Montpellier, France) and the recom-
mendations of the Helsinki Declaration.
Animal preparation
We used the same experimental design described in our
previous studies [17,21,22]. In brief, 12 piglets (15 to
20 kg) were anesthetized with intravenous pentobarbital
sodium (5 to 6 mg/kg). Piglets had their tracheas intu-
bated with a cuffed endotracheal tube, and anesthesia
was maintained with continuous intravenous propofol,
midazolam, and ketamine without neuromuscular block-
ing agents. The depth of anesthesia was monitored with
bispectral index (BIS; Aspect, Norwood, MA, USA) [23]
and was adjusted to block the respiratory drive in both
groups. The absence of spontaneous breathing was
checked on the ventilator trend graphs, and electromyo-
graphic activity of the diaphragm was recorded in a few
animals to confirm the absence of electrical activity
[17,22].
Volume-controlled ventilation was performed by using
an ICU ventilator (Galileo; Hamilton Medical AG, Rha-
zuns, Switzerland). The following ventilator settings were
determined to achieve normocapnia and were maintained
throughout the whole experiment: inspired fraction of
oxygen (FiO2), 0.35; tidal volume (TV), 10 to 12 ml/kg;
respiratory rate (RR), 15 to 30 cycles per minute; and posi-
tive end-expiratory pressure (PEEP), 5 cm H2O. An oral
gastric tube and a bladder catheter were placed. Heating
pads were used as needed to maintain a normal body tem-
perature of 38.5°C to 39.5°C. Parenteral nutrition was given
from the first day, providing 30 to 35 kcal/kg per day. The
animals received prophylactic intravenous antibiotics
3 times daily (amoxicillin-clavulanate, 100 mg/kg per day).
After surgical preparation of the right carotid artery, a
carotid arterial line (PiCCO; Pulsion, Munich, Germany)
was inserted for monitoring of the heart rate, arterial
blood pressure, and cardiac output. Arterial and end-tidal
CO2 partial pressure were checked with a capnograph
(Deltatrac; Datex-Ohmeda, Helsinki, Finland) each
4 hours and with arterial blood gases each 12 hours
(iSTAT; Abbott, Abbott Park, IL, USA).
A physician provided round-the-clock supervision and
animal care for the entire duration of the study. The
two groups received the same care, except for the level
of capnia.
Ventilatory care
Animals were separated into two groups in which studied
variables were measured each 12 hours: a control group
(n = 6), mechanically ventilated in normocapnia without
any intervention, and a hypercapnia group (n = 6),
exposed to a determined level of moderate hypercapnic
acidosis over a prolonged period. In the hypercapnia
group, we increased the instrumental dead space, without
any modifications of tidal volume or respiratory rate, to
maintain the PaCO2 in the range of 55 to 70 mm Hg.
Assessment of diaphragm muscle activity during
mechanical ventilation
In vivo assessment of transdiaphragmatic pressure
Every 12 hours, we measured transdiaphragmatic pres-
sure (Pdi) to assess in vivo diaphragmatic contractile
force in both groups, as described in previous studies
[17,22]. In brief, double air-filled balloon-tipped catheters
were placed transorally into the distal third of the eso-
phagus and in the stomach for measurement of Pdi.
Bipolar transvenous pacing catheters were introduced via
each internal jugular vein and adjusted to achieve stimu-
lation of the phrenic nerve and subsequent contraction
of the diaphragm. Pdi was produced by supramaximal sti-
mulation at frequencies of 20, 40, 60, 80, 100, and 120 Hz
in a serial manner. Each train of impulses lasted of 2,000
ms, and each pulse had duration of 150 ms. A pressure-
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frequency curve was obtained for both groups at each 12-
h period and were then compared.
Statistical analysis
Data are presented as mean ± SD, unless specifically
indicated. Normality of the distribution was assessed
with the Kolmogorov-Smirnov test.
Comparison of several means was performed by using a
repeated-measures analysis of variance and the Newman-
Keuls test. A two-way analysis of variance with time (H0,
H12, H24,..., to H72) as one factor and modality (normo-
capnia versus hypercapnia) as the other factor was used.
When appropriate, a post hoc PLSD Fisher test was used.
Nonparametric paired Wilcoxon tests were used to com-
pare data from days 1 and 3 for each animal in both
Normocapnia and Hypercapnia groups. All P values were
two-tailed and a P value < 0.05 was considered significant
(StatView, version 5.0; SAS Institute Inc., Berkeley,
CA, USA).
Results
Systemic and biologic response to mechanical ventilation
Long-term mechanical ventilation (that is, 72 hours),
either in normocapnia or hypercapnia, did not have conse-
quences on body weight, intestinal transit, diuresis (data
not shown) or hemodynamic variables (Table 1). Hyper-
capnia was associated with an increased cardiac output
over time, mainly related to the increase of heart rate.
Ventilator parameters were comparable among groups.
Surprisingly, PaO2 was higher in the Hypercapnia group
than in the Normocapnia group, although none of the pig-
lets was hypoxemic. We did not observe any significant
differences between the Normocapnia and Hypercapnia
groups for all the studied baseline variables. Although BIS
values were not significantly different between Normocap-
nia and Hypercapnia groups (38 ± 8 versus 42 ± 12; P >
0.99), mean midazolam-level administration remained at a
higher level in the Hypercapnia group (5.1 ± 0.6 mg/h)
than in the Normocapnia group (3.5 ± 0.6 mg/h) during
the study (P < 0.05 between Normocapnia and Hypercap-
nia groups after 12 hours of ventilation). Doses of propofol
were higher in the Hypercapnia group in comparison with
the Normocapnia group (102 ± 8 mg/h and 135 ± 49
mg/h in Normocapnia and Hypercapnia groups, respec-
tively, P < 0.05 after 12 hours of ventilation).
In vivo assessment of diaphragmatic force
The baseline pressure-frequency curves of the two groups
were not significantly different (Pdi at 20 Hz = 32.7 ± 8.7
cm H2O versus 34.4 ± 8.4 cm H2O; and at 120 Hz = 56.8
± 8.7 cm H2O versus 60.8 ± 5.7 cm H2O, for Normo-
capnia and Hypercapnia groups, respectively) (Figure 1A
and 1B).
Although Pdi decreased significantly in the Normocap-
nia group between baseline and H72 at all frequencies
except 20 Hz (Figure 1A) (P < 0.05), it did not change
significantly in the Hypercapnia group (Figure 1B). The
force decreased significantly after 48 hours of mechanical
ventilation in the Normocapnia group, whereas it
remained stable in the Hypercapnia group (Figure 2A
and 2B).
Discussion
This study shows that although prolonged totally con-
trolled mechanical ventilation in normocapnia alters dia-
phragm contractility in vivo, maintaining a moderate
hypercapnic acidosis during prolonged (72 continuous
hours) controlled mechanical ventilation seems to prevent
VIDD.
VIDD related to totally controlled mechanical ventilation
has been well described, both in several animal studies
[17,21,22,24-29] and recently in humans [4-8]. Maintaining
diaphragm at rest in the present study (Normocapnia
group) effectively promoted VIDD (Figure 1).
Hypercapnic acidosis is frequently observed in critically
ill patients. Hypercapnic acidosis can be acute, and as
such is often a consequence of an acute disease (acute
respiratory failure, hypnotic or opioids overdose), or can
be moderate and prolonged, as a consequence of a “pro-
tective setting” of mechanical ventilation. The physiologic
consequences of hypercapnic acidosis on the brain and
the cardiovascular system have been well described and
include cerebral hypertension, pulmonary artery vasocon-
striction, severe tachycardia, and coma [30,31]. Acute
hypercapnic acidosis has been implicated in diaphragm
dysfunction in animal studies [17,32-34] as well as in
healthy human volunteers [20,35,36]. We recently
reported that the recovery of diaphragm contractility
impairment related to acute hypercapnic acidosis was
incomplete 1 hour after the return to normocapnia [17].
This impairment was associated with the severity of the
acidosis and might be partially reversed by inotropes
such as dopamine [18] or dobutamine [19]. In opposition
to severe and acute hypercapnic acidosis, beneficial
effects of moderate hypercapnic acidosis (pH 7.20 to 7.30
and/or PaCO2 50 to 70 mm Hg) have been reported on
lung inflammation during acute lung injury with or with-
out bacterial pneumonia [13,37-39]. In addition, moder-
ate hypercapnic acidosis may increase cardiac index
without increasing oxygen consumption during septic
shock [31]. However, few data concern the consequences
of moderate hypercapnic acidosis on muscles, in particu-
lar, the diaphragm. In the present study, we report for
the first time that moderate hypercapnic acidosis seems
to prevent VIDD in comparison with normocapnia.
Although totally controlled mechanical ventilation with
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normocapnia during 72 continuous hours led to a 25%
decrease of Pdi, evaluated in vivo (Figure 1), no signifi-
cant differences existed between baseline and H72 in the
moderate hypercapnic acidosis group. The mechanisms
of VIDD related to totally controlled mechanical ventila-
tion have been well described in several animal models,
including piglets [22,24,40,41]. The main mechanisms
include the stimulation of proteolysis, apoptosis oxidative
stress, protein synthesis impairment, autophagy, and sar-
comeric lesions [17,28,40-44]. Although those mechan-
isms have been well explored, very few countermeasures
have been reported. Those countermeasures include
Table 1 Hemodynamic and respiratory variables for the seven steps of measures between the Normocapnia (n = 6)
and the Hypercapnia (n = 6) groups
H0 H12 H24 H36 H48 H60 H72
Minute ventilation (L/min)
Normocapnia 5.9 ± 0.8 4.4 ± 0.6 5.1 ± 0.6 4.9 ± 0.5 4.7 ± 0.4 4.8 ± 0.6 4.7 ± 0.8
Hypercapnia 4.6 ± 0.3 4.3 ± 0.1 5.1 ± 0.2 4.8 ± 0.3 4.2 ± 0.2 4.8 ± 0.2 4.3 ± 0.2
Tidal volume (ml)
Normocapnia 240 ± 40 220 ± 20 230 ± 20 230 ± 25 225 ± 25 230 ± 25 205 ± 10
Hypercapnia 230 ± 22 225 ± 15 235 ± 30 240 ± 15 235 ± 30 230 ± 20 240 ± 20
Respiratory rate (c/min)
Normocapnia 24 ± 3 20 ± 3 22 ± 2 22 ± 2 21 ± 1 21 ± 1 20 ± 1
Hypercapnia 20 ± 6 19 ± 5 19 ± 4 20 ± 3 18 ± 6 19 ± 4 18 ± 3
Peak pressure (cm H2O)
Normocapnia 22 ± 1 23 ± 2 22 ± 1 21 ± 3 23 ± 2 22 ± 3 23 ± 3
Hypercapnia 22 ± 3 21 ± 2 20 ± 2 22 ± 2 20 ± 3 20 ± 3 20 ± 2
Plateau pressure (cm H2O)
Normocapnia 14 ± 2 14 ± 3 13 ± 2 14 ± 3 13 ± 2 14 ± 4 15 ± 2
Hypercapnia 13 ± 1 14 ± 3 12 ± 3 13 ± 2 12 ± 4 13 ± 3 13 ± 3
pH
Normocapnia 7.52 ± 0.02 7.47 ± 0.06 7.46 ± 0.04 7.45 ± 0.01 7.44 ± 0.04 7.47 ± 0.04 7.44 ± 0.05
Hypercapnia 7.43 ± 0.07 7.31 ± 0.09ab 7.29 ± 0.05ab 7.30 ± 0.06ab 7.27 ± 0.07ab 7.25 ± 0.08ab 7.22 ± 0.04ab
PaO2 (mm Hg)
Normocapnia 99 ± 8 97 ± 6 95 ± 5 98 ± 3 95 ± 6 97 ± 5 101 ± 6
Hypercapnia 147 ± 8a 148 ± 5a 149 ± 4a 132 ± 4a 115 ± 8a 146 ± 6a 110 ± 9
PaCO2 (mm Hg)
Normocapnia 33 ± 6 39 ± 3 41 ± 3 40 ± 3 39 ± 3 38 ± 2 37 ± 3
Hypercapnia 44 ± 7a 65 ± 8ab 70 ± 3ab 77 ± 8ab 73 ± 10ab 66 ± 7ab 73 ± 4ab
SaO2 (%)
Normocapnia 98 ± 2 99 ± 2 97 ± 3 100 ± 2 98 ± 2 97 ± 3 96 ± 4
Hypercapnia 99 ± 2 98 ± 1 97 ± 4 99 ± 2 99 ± 4 98 ± 3 99 ± 3
Plasma bicarbonate (mM)
Normocapnia 27 ± 4 29 ± 4 29 ± 5 29 ± 3 27 ± 3 30 ± 2 26 ± 2
Hypercapnia 28 ± 4 35 ± 5ab 33 ± 3ab 35 ± 2ab 34 ± 5ab 32 ± 4b 32 ± 5ab
Heart rate (c/min)
Normocapnia 101 ± 10 106 ± 12 107 ± 12 103 ± 10 97 ± 8 101 ± 14 101 ± 15
Hypercapnia 93 ± 18 96 ± 27 91 ± 26 118 ± 26ab 123 ± 12ab 118 ± 12ab 114 ± 16ab
Mean blood pressure (mm Hg)
Normocapnia 75 ± 7 80 ± 10 88 ± 7 86 ± 9 84 ± 13 83 ± 13 88 ± 14
Hypercapnia 83 ± 15 72 ± 14 76 ± 16 87 ± 18 86 ± 22 79 ± 15 77 ± 15
Cardiac Output (l/min)
Normocapnia 2.2 ± 0.3 2.7 ± 0.3 2.8 ± 0.5 2.8 ± 0.2 2.7 ± 0.2 2.7 ± 0.2 2.7 ± 0.3
Hypercapnia 2.8 ± 0.4 2.9 ± 0.6 3.1 ± 0.6 3.8 ± 0.5ab 3.3 ± 0.7ab 3.2 ± 0.6ab 3.4 ± 0.7ab
Stroke volume (ml)
Normocapnia 22 ± 7 27 ± 10 27 ± 11 28 ± 8 29 ± 10 27 ± 11 26 ± 12
Hypercapnia 28 ± 8 29 ± 12 32 ± 9 28 ± 14 27 ± 8 27 ± 10 30 ± 8
Data are expressed as mean ± SD. aP < 0.05 between Normocapnia and Hypercapnia groups; bP < 0.05 intragroup difference between time considered and
baseline. PaO2, arterial pressure of oxygen; PaCO2, arterial pressure of carbon dioxide; SaO2, oxygen saturation of arterial blood.
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pharmacologic interventions, such as antioxidative mole-
cules [45-48] or high-dose steroids [49], but also ventila-
tory measures, such as maintaining spontaneous
ventilatory cycles during mechanical ventilation [50-52].
The present study reports that moderate and pro-
longed hypercapnic acidosis decreases the diaphragm
impairment related to prolonged totally controlled
mechanical ventilation. The mechanism of the observed
A B
Figure 1 Diaphragmatic pressure/frequency curves obtained in the Normocapnia group (A) (n = 6) and in the Hypercapnia group
(B) (n = 6). Transdiaphragmatic pressure (Pdi) after supramaximal phrenic nerve stimulation at 20, 40, 60, 80, 100, and 120 Hz over a period
of 72 hours of mechanical ventilation were obtained in both groups. In the Normocapnia group, Pdi significantly decreased between
baseline and H72 at all frequencies (except at 20 Hz) (P < 0.05). No significant differences between baseline and H72 were observed for the
values obtained at all frequencies in the Hypercapnia group. Data are expressed as mean ± SD. NS, not significant. P values refer to between
H72 versus baseline.
Figure 2 Transdiaphragmatic pressure (Pdi) expressed as percentage of Pdi at normocapnia obtained at 100 Hz stimulation at each
stimulation (every 12 hours) in the Normocapnia group (A) (n = 6) and in the Hypercapnia group (B) (n = 6). Pdi was significantly lower
at 100 Hz compared with H0 after 48 hours of mechanical ventilation in the normocapnia group (A). Conversely, no significant decreases were
noted in Pdi between the successive measures in the hypercapnia group (B). Data are expressed as percentage (mean ± SD). NS, not significant.
P values refer to between H72 versus baseline.
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“protective” effect of moderate and prolonged acute
hypercapnic acidosis is not known and was not explored
in the present study.
In the present study, hypercapnic acidosis was associated
with an increased cardiac output, even with higher doses
of anesthetic drugs (Table 1). Mechanical ventilation perse
has been reported to impair diaphragm blood flow [53],
and whether prolonged and moderate hypercapnic acido-
sis may prevent this impairment has not been studied. We
can speculate that one of the hypothetical mechanisms
could be better diaphragm perfusion, although we did not
measure the diaphragm blood flow. Another potential
mechanism that might have played a role is the increased
oxygen delivery to the tissues due to hypercapnic acidosis
[54,55]. Moderate hypercapnic acidosis has been demon-
strated to possess potent antioxidant properties in the
lung, both in vitro and in vivo [14,16,38], by using biomar-
kers such as isoprostane or the in vitro generation of uric
acid from addition of xanthine oxidase to purine in an iso-
lated buffer-perfused rabbit lung [16]. Furthermore, hypo-
capnic alkalosis significantly increased H2O2-induced
apoptosis and caspase activation of A549 lung cells [56],
suggesting that hypocapnic alkalosis may intensify oxida-
tive-induced apoptosis of alveolar epithelial cells via
increasing cytosol level of calcium, a strong stimulus of
calpain- and caspase-related proteolysis. Regarding those
studies, we could speculate that moderate hypercapnic
acidosis may inhibit calcium-dependent proteases, thereby
limiting the extent of atrophy related to prolonged con-
trolled mechanical ventilation. Moderate hypercapnic
acidosis may also promote the transition from glycolytic,
type II fibers to type I fibers after several days of hypercap-
nic acidosis exposure in an animal model [57]. Recently
and in opposition to normocapnia, moderate hypercapnia
(PaCO2 equal to 75 mm Hg) during an 18-hour period of
mechanical ventilation in rats was associated with a higher
diaphragmatic force, a decrease in diaphragmatic IL-6 and
KC pro-inflammatory cytokines, and an increase in dia-
phragmatic antiinflammatory cytokine IL-10 level [58].
Another well-known effect of moderate hypercapnic
acidosis is the inhibition of inflammation process related
to mechanical ventilation in healthy or acutely injured
lungs [13,38].
Some study limitations must be pointed out. First, we
did not compare our results with a control group with-
out anesthesia, or mechanical ventilation, because large
animals must be anesthetized for procedures such as
phrenic stimulation and Pdi recording.
Second, in the hypercapnia group, to obtain a similar
sedation level and to neutralize the centers of breathing,
higher levels of propofol and midazolam doses were
required. Therefore, we cannot eliminate a direct effect
of sedation on Pdi. However, in the clinical situation,
sedation is frequently necessary to ensure patient/ventila-
tor synchrony with the controlled mechanical ventilation
mode. Although this point clearly represents a methodolo-
gic limit of our study, it reflects the clinical interaction
between sedation and mechanical ventilation.
Third, PaO2 values in the hypercapnia group were
slightly above the PaO2 levels in the normocapnia group.
However, because mean PaO2 in the normocapnia group
was 350 mm Hg, it is doubtful that this could represent
the leading cause of the protective effect observed in the
hypercapnia group.
Finally, we do not provide mechanistic analysis for this
study.
Conclusions
The present study reports that prolonged and moderate
hypercapnic acidosis may protect against VIDD in a
totally controlled mechanically ventilated piglet model.
Key messages
• Prolonged controlled mechanical ventilation with
normocapnia is associated with a diaphragm contracti-
lity impairment and ventilator-induced diaphragmatic
dysfunction.
• In opposition, prolonged ventilation with moderate
hypercapnic acidosis seems to prevent VIDD in a
72-hour healthy piglet study.
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